IOP, Inc. Establishes Commercialization Alliance with Light BioScience, LLC.

Print This Post

COSTA MESA, California – 1 August 2003- IOP Inc., the premier developer and distributor of specialty technologies for eye surgery, announces the alliance formation with Light BioScience LLC for marketing and distribution of skin rejuvenation technology.

Light BioScience, LLC. (Virginia Beach, VA) is on the forefront of the science of LED Phototherapy. NASA researchers developed the science of using light energy to manipulate activity in living cells. Light Bioscience took this research several steps further to establish clinical applications for this unique non-thermal technology. Combinations of light wavelength, intensity and exposure period, were utilized to establish a proprietary “code” to stimulate collagen synthesis in cultured fibroblasts. This research led to the development of the Gentlewaves, LED photomodulation device for non-invasive dermal enhancement.

Elective aesthetic procedures such as Botox® injections and blepharoplasty represent a major growth segment in the ophthalmic practice. These procedures help fill the demographic void between the LASIK corrective market segment and the treatment of age related ophthalmic diseases.

The system is unique to other non-ablative therapies in that it causes no thermal injury to establish the desired effect. LED photomodulation may be utilized in conjunction with most aesthetic procedures and is suitable for all skin types. The ease of use and functionality provide the general and refractive ophthalmologist the opportunity to establish a cosmetic practice segment.

About IOP

Founded in 1988, IOP, Inc. develops and commercializes specialized, leading-edge surgical technologies for eye surgery. IOP’s purpose is to develop surgical solutions that improve the quality of life for patients, elevate the performance and productivity of eye care professionals, and lower costs to the provider.

IOP currently holds leadership positions with surgical devices for oculoplastic surgeries and bio-implant technologies for cornea, anterior and oculoplastic surgeries.

This entry was posted in News. Bookmark the permalink.

Author: admin

Leave a Reply

Your email address will not be published. Required fields are marked *


You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>